Women (trigger): 5,000-10,000 IU single subcutaneous dose 36 hours before retrieval/IUI
Can I split doses differently
Although BPC-157 isnt approved by the U.S
The advanced autoantibody panel, Neural Zoomer Plus , screens for immune reactivity to key neural targets, including myelin basic protein, NMDA receptors, gangliosides, synapsin, S100B, and blood-brain barrier proteins
Unregulated online sources may contain impurities, incorrect dosing, or degraded product that introduces risks unrelated to BPC-157's actual pharmacology
Dose may be increased to 9 mg once daily if additional glycemic control is needed after at least 30 days on the 4 mg dose